Dr. Carlos E. Campo, MD

Dr. Campo practices at Tallahassee Memorial Hospital in Tallahassee, Florida, part of Tallahassee Memorial HealthCare.

Dr. Campo's NPI, 1912922071, was assigned on July 12, 2006. Dr. Campo graduated from Universidad de Ciencias Medicas in 1990. Dr. Campo holds Florida license ME64652.

Dr. Campo's primary practice is Tallahassee Memorial Hospital, at 1300 Miccosukee Rd, Tallahassee, FL 32308 in Leon County. The practice phone is (850) 431-1155.

Dr. Campo's primary practice is Tallahassee Memorial Hospital in Tallahassee, Florida, part of Tallahassee Memorial HealthCare. Dr. Campo is also affiliated with HCA Florida Capital Hospital. The medical group on file is TMH Physician Partners. Dmand AI also links Dr. Campo to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Campo practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Campo's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Campo is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Campo is licensed in Florida.

Dmand AI lists asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pulmonary fibrosis, pulmonary heart disease, sleep apnea and tobacco use among the conditions Dr. Campo treats.

CMS data shows 1,142 Medicare services from Dr. Campo across 12 procedure codes in 2024, for 487 Medicare patients. Medicare paid $127,992 for them.

CMS counts 487 Medicare patients who saw Dr. Campo in 2024. The largest group is 75 to 84, with 203 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Campo's median patient age at 72, with 47% women.

In 2024, Dr. Campo wrote 901 Medicare Part D claims for 157 patients. 47% of them were for generic drugs. CMS names the drug for 768 of them, across 21 drugs with 11 or more claims each, at $505,128 in total drug cost. In 2023, CMS named 622 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Campo for performance year 2024, reported as part of a group. Dr. Campo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Dr. Campo, published from 2011 to 2020. The most frequent topics are Bronchial Hyperreactivity, Bronchoconstriction and Molecular Weight. Dr. Campo has published most often in Am J Respir Crit Care Med. Dr. Campo's most frequent co-authors are Tahir Ahmed, MD, Rafael E. Campo, MD and David Ashkin, MD.

CMS Open Payments shows 727 general payments to Dr. Campo from 58 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 79% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $87,589.

Dmand AI lists 1 award for Dr. Campo, most recently CMS Stage 1 2012 in 2011.

Dr. Campo graduated from Universidad de Ciencias Medicas in 1990. Dr. Campo is a member of ACCP, SCCM, ACP and ATS.

Dr. Campo is in network with 17 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.